Drug Trial Radar · NCT07186946
Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants
Last checked: Nov 20, 2026Latest source record: Jan 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Sep 15, 2025
Primary completion
Oct 20, 2025
Study completion Oct 20, 2025
Sponsor
- Lead sponsor
- Thryv TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A research study that involves the use of an investigational drug called THRV-1268. The main purpose is to measure the safety (whether it causes any side effects) and tolerability (if it does cause any side effects, how well your body is able to handle them) in healthy obese adults. This study will also look at how the drug moves through the body, is absorbed, distributed, metabolized and eliminated.
Conditions
- Heart Failure
Interventions
THRV-1268Drug
THRV-1268 a serum glucocorticoid regulated kinase 1 (SGK-1) inhibitor
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evalute the safety and tolerability of a single oral doseTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dr. Vince Clinical Research
Overland Park, Kansas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.